Clinical Trials
15 trialsNCT05724121 2026-06-03
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
National Institutes of Health Clinical Center (CC)
Recruiting
NCT05184790 2026-05-19
LEARN
University of Sydney
Recruiting
NCT07348991 2026-02-10
Predicting Severe Cardiac Arrhythmias in the Perioperative Period Using AI-ECG
I.M. Sechenov First Moscow State Medical University
Not yet recruiting
NCT05094843 2025-09-10
The Cardiac Stress and Electrocardiographic Changes Caused by Lung Cancer Surgery
Tampere University Hospital
Recruiting
NCT03098589 2025-03-30
Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)
Celgene
Completed
NCT06001073 2024-07-12
PROSPECT
First Affiliated Hospital Xi'an Jiaotong University
Recruiting
NCT03840928 2023-12-13
PatientSpot Formerly Known as ArthritisPower
Global Healthy Living Foundation
Unknown
NCT06073509 2023-11-08
WATCH
Institut de Radioprotection et de Surete Nucleaire
Unknown
NCT01431326 2023-09-06
PTN_POPS
Duke University
Completed
NCT05226416 2023-05-09
ACTIV4
Eurasian Association of Therapists
Completed
NCT02921828 2022-07-05
A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg
Celgene
Completed
NCT02921802 2022-06-14
A Study of Special Use Results Surveillance of Revlimid 5mg Capsules
Celgene
Completed
NCT02922543 2022-06-14
A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use
Celgene
Completed
NCT04407780 2020-05-29
CONFUCIUS
European Georges Pompidou Hospital
Recruiting
NCT03243604 2018-10-18
ARBITRAGE
Groupe Hospitalier Pitie-Salpetriere
Completed